NCTN Core Correlative Sciences Committee (NCTN-CCSC)
Cancer Therapy Evaluation Program (CTEP)-registered investigators may submit proposals to use banked, non-reserved biospecimens from phase 2/3 or phase 3 NCTN clinical trials in correlative science studies.
These biospecimens are highly annotated with carefully collected clinical data, including outcome data. To ensure optimal use of these irreplaceable clinical trial biospecimens, proposals are reviewed and prioritized by the NCTN CCSC, a committee of representatives from NCTN and NCI with expertise in oncology, laboratory science, translational medicine, pathology, statistics, biobanking, and patient advocacy.
Download CCSC Overview Slides for more information or browse the list of approved CCSC studies to learn more about the projects we support.
Contact Us
- NCTN-CCSC Coordinator: NCINCTN-CCSC@mail.nih.gov
- Navigator Front Door Service: navigatorcontact@imsweb.com
- Protocol Information Office (PIO): pio@ctep.nci.nih.gov
Proposal Process
-
Evaluation Guidelines
Review the criteria used to prioritize hypothesis-validation studies and the situations in which exploratory proposals may be considered.
-
Submission and Review
Find tips for creating a strong proposal and learn what to expect from the CCSC review process after submission.
-
After Approval
Obtain your specimens from the NCTN group biobank and review your publication and data sharing obligations as an NCI investigator.